Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Investigation
|
October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
Fumou Sun, Yan Cheng, Jin-Ran Chen, et al.
JAMA Oncology
|
June 5, 2025
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials
Samer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Blood Advances
|
December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up
Samer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
JNCI Cancer Spectrum
|
November 25, 2023
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review
Jawad Alrawabdeh, Marah Alzu'bi, Muntaser Alzyoud, et al.
Blood Advances
|
August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
Carolina Schinke, Alexandra M Poos, Michael Bauer, et al.
British Journal of Haematology
|
January 2, 2026
Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review
Karun Neupane, Mitch Singstock, Darshi Shah, et al.
Cancer Biomarkers : Section a of Disease Markers
|
June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma
Fumou Sun, Yan Cheng, Catherine Ma, et al.
The Oncologist
|
September 5, 2024
Evaluating early intervention in smoldering myeloma clinical trials: a systematic review
Apoorva Kakkilaya, Aaron Trando, Edward R Scheffer Cliff, et al.
Blood Cancer Journal
|
November 7, 2025
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Samer Al Hadidi, Aniko Szabo, Bhavesh Mohan Lal, et al.
Bone Marrow Transplantation
|
November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Dawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Investigation
|
October 26, 2023
BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions
Fumou Sun, Yan Cheng, Jin-Ran Chen, et al.
JAMA Oncology
|
June 5, 2025
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical Trials
Samer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
Blood Advances
|
December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up
Samer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.
JNCI Cancer Spectrum
|
November 25, 2023
Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review
Jawad Alrawabdeh, Marah Alzu'bi, Muntaser Alzyoud, et al.
Blood Advances
|
August 17, 2022
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
Carolina Schinke, Alexandra M Poos, Michael Bauer, et al.
British Journal of Haematology
|
January 2, 2026
Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review
Karun Neupane, Mitch Singstock, Darshi Shah, et al.
Cancer Biomarkers : Section a of Disease Markers
|
June 9, 2025
Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma
Fumou Sun, Yan Cheng, Catherine Ma, et al.
The Oncologist
|
September 5, 2024
Evaluating early intervention in smoldering myeloma clinical trials: a systematic review
Apoorva Kakkilaya, Aaron Trando, Edward R Scheffer Cliff, et al.
Blood Cancer Journal
|
November 7, 2025
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Samer Al Hadidi, Aniko Szabo, Bhavesh Mohan Lal, et al.
Bone Marrow Transplantation
|
November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study
Dawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Page
of 10